All comparisons

Educational Wellness Information Only

This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.

Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.

Cognitive comparison

Selank vs Zilucoplan (Zilbrysq)

An educational, source-based comparison of Selank and Zilucoplan (Zilbrysq) — how each peptide works, what it's researched for, and what to know before going deeper.

Anxiolytic · Nootropic
Selank

Anxiolytic-style peptide researched for stress modulation.

Mechanism

A synthetic analog of the immunomodulatory peptide tuftsin. Research suggests it modulates GABAergic and serotonergic systems and influences expression of brain-derived neurotrophic factor without the sedation or dependence profile of benzodiazepines.

Research areas
  • Generalized anxiety models
  • BDNF expression
  • Immune modulation
  • Memory and learning in rodent models
Considerations
  • Not FDA-approved.
  • Most studies are Russian clinical literature.
Full Selank profile →
Complement Inhibitor · Neuromuscular
Zilucoplan (Zilbrysq)

Macrocyclic peptide complement C5 inhibitor for generalized myasthenia gravis.

Mechanism

A synthetic 15-amino-acid macrocyclic peptide that binds complement component C5 and blocks its cleavage to C5a/C5b, preventing formation of the membrane attack complex at the neuromuscular junction. Self-administered subcutaneously.

Research areas
  • Generalized myasthenia gravis (anti-AChR antibody positive)
Considerations
  • FDA-approved 2023.
  • Requires meningococcal vaccination — risk of serious meningococcal infection.
  • Injection-site reactions common.
Full Zilucoplan (Zilbrysq) profile →

Selank vs Zilucoplan (Zilbrysq) — Key differences

  • Class: Selank is classified as Anxiolytic · Nootropic, while Zilucoplan (Zilbrysq) is Complement Inhibitor · Neuromuscular.
  • Primary research focus: Selankgeneralized anxiety models; Zilucoplan (Zilbrysq)generalized myasthenia gravis (anti-achr antibody positive).
  • Tag: Calm · Cognition vs FDA-Approved · Neuromuscular.

Related comparisons